Chromium supplements might aid in slight weight loss, but evidence is limited.
Chromium supplements might aid in slight weight loss, but evidence is limited.
This study explored whether taking chromium picolinate, a type of dietary supplement, could help overweight or obese adults lose weight. Researchers found that people who took chromium lost about 1 kilogram (approximately 2.2 pounds) more than those who took a placebo, over 8 to 24 weeks. However, the evidence was not strong enough to be sure of its effectiveness, and some participants experienced side effects. For seniors interested in weight management, this suggests chromium might offer slight benefits, but it's important to consult with healthcare providers before starting any new supplement.
Use the full description to understand the study design, methods, and the limits of the findings.
The study involved nine trials where overweight or obese adults took chromium supplements or a placebo for 8 to 24 weeks. The findings showed a slight weight loss in those taking chromium.
The study was a collection of randomized controlled trials with 622 participants, comparing chromium picolinate to a placebo over a short period.
Participants taking chromium lost about 1 kilogram more than those on placebo, but the evidence was considered low quality due to study limitations.
There were some reports of side effects, including serious ones, and the long-term effects of chromium are unknown.
Seniors should discuss with healthcare professionals before considering chromium supplements for weight loss.
Open the original publication for the complete methods, outcomes, and source material.
This study is a well-conducted meta-analysis of RCTs on chromium picolinate supplementation for weight loss in overweight or obese adults. It uses rigorous methods typical of Cochrane reviews, including a comprehensive search strategy and risk of bias assessment. However, the evidence quality is rated as low, and the study does not specifically focus on seniors, which limits its direct applicability to the senior population.
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 10.0/10 | |
| Bias & Methods | 8.3/10 | |
| Statistical Integrity | 10.0/10 | |
| Transparency | 10.0/10 | |
| Conflict of Interest Disclosure | 10.0/10 | |
| Replication / External Validation | 10.0/10 | |
| Relevance to Seniors | 5.0/10 | |
| Journal Quality | 10.0/10 |
The study's conclusions highlight the lack of reliable evidence for chromium picolinate's efficacy and safety, which is important for informing clinical decisions.
Review the interventions studied here and compare them against the broader treatment library.
Build a personalized plan using research-backed studies, conditions, and treatments.